Candriam SCA’s UiPath PATH Stock Holding History

Candriam SCA’s Portfolio PATH Stock Details PATH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-149,307	Closed	-$2M	–	709
2025 Q3	$2M	Sell	149,307 -335,370	-69%	-$3.96M	0.01%	503
2025 Q2	$6.2M	Sell	484,677 -1,305,636	-73%	-$15.7M	0.04%	317
2025 Q1	$18.4M	Buy	+1,790,313	New	+$23M	0.12%	168

Other funds holding PATH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Candriam SCA's PATH Position: Q4 2025 in Review

Candriam SCA sold out of UiPath (PATH) in Q4 2025, closing a stake of 149,307 shares — an estimated $2M sold.

Candriam SCA first reported a position in PATH in Q1 2025 and held it in 3 quarters. The position peaked at $18.4M in Q1 2025. 539 funds tracked by Wall St. Rank hold PATH as of Q4 2025.

Candriam SCA reported no remaining UiPath position as of Q4 2025 after selling out during the quarter.
Candriam SCA sold 149,307 UiPath shares in Q4 2025, an estimated $2M.
Candriam SCA first reported a position in UiPath in Q1 2025 and held it in 3 quarters.
Candriam SCA's UiPath position peaked at $18.4M in Q1 2025.
539 funds tracked by Wall St. Rank held UiPath as of Q4 2025.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.